Early stage life sciences company iBIONICS has had “a phenomenal year of growth and learning,” says CEO and co-founder Suzanne Grant.
The company, which is developing a bionic-eye system to restore vision in people with retinal degenerative diseases, has reached combined private and public funding goals of US$2.5 million and added another $1.5 million in grants; it also expects to finalize additional pre-seed financing in the next two quarters.
The firm has secured an exclusive worldwide licence for its prototype and has recently celebrated several other business and technical milestones.
OBJ360 (Sponsored)
Don’t get left behind: Keep pace with the job market by AI upskilling at uOttawa
uOttawa’s Paula Branco was a math teacher in Portugal for more than a decade before deciding to boost her career by going back to school. “I’m one of those people
Minto’s Metro Towns at Anthem in Barrhaven & Parkside in Kanata offer attainable home ownership
Guided by the needs of homeowners, Minto has been building new homes and master-planned communities across Canada and the USA for 70 years. To ensure the best quality of life
Ms. Grant and iBIONICS were also chosen to exhibit at the Accessibility Innovation Showcase at the Invictus Games in Toronto in September.
